About Mitral Valve
The mitral valve manages blood flow from the left atrium to the left ventricle. The valve prevents the backward flow of the blood. Mitral regurgitation is a common mitral valve disorder that causes the abnormal backward flow of the blood. Cardiologists use mitral surgical valve repair procedures or transcatheter replacement procedures to treat this disorder. About 80,000 individuals undergo these two procedures for treating the disorder.
Technavio’s analysts forecast the global transcatheter mitral valve replacement market to grow at a CAGR of 21.93% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global transcatheter mitral valve replacement market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of transcatheter mitral valve implants.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Transcatheter Mitral Valve Replacement Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott Laboratories
• Edwards Lifesciences
• Micro Interventional Devices
• Neovasc
Other prominent vendors
• MitrAssist
• NaviGate Cardiac Structures
• Valtech
• Boston Scientific
• Medtronic
Market driver
• Use of minimally invasive procedures
• For a full, detailed list, view our report
Market challenge
• Stringent regulatory framework
• For a full, detailed list, view our report
Market trend
• Increase in M&A
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by product
• Transfemoral implantation
• Transapical implantation
PART 07: Reimbursement and economics of transcatheter mitral valve replacement in US
• Reimbursement for transcatheter mitral valve replacement
• Economic impact of transcatheter mitral valve replacement
PART 08: Geographical segmentation
• Transcatheter mitral valve replacement market in Americas
• Transcatheter mitral valve replacement market in EMEA
• Transcatheter mitral valve replacement market in APAC
PART 09: Market drivers
• Prevalence of mitral regurgitation
• Use of minimally invasive procedures
• Use of transcatheter mitral valve replacement in high-risk individuals
PART 10: Impact of drivers
PART 11: Market challenges
• Availability of alternative treatment
• Stringent regulatory framework
• Lack of skilled personnel
PART 12: Impact of drivers and challenges
PART 13: Market trends
• Development of novel products
• Increase in M&A
• Focus on US
PART 14: Vendor landscape
• Competitive scenario
• Product portfolio matrix
PART 15: Key vendor analysis
• Abbott Laboratories
• Edwards Lifesciences
• Micro Interventional Devices
• Neovasc
• Other prominent vendors
PART 16: Appendix
• List of abbreviations
PART 17: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global transcatheter mitral valve replacement market 2015-2020 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global transcatheter mitral valve replacement market segmentation by product
Exhibit 05: Comparison of transfemoral and transapical implantation
Exhibit 06: Global transcatheter mitral valve replacement market segmentation by geography 2015
Exhibit 07: Global transcatheter mitral valve replacement market segmentation by geography 2020
Exhibit 08: Global transcatheter mitral valve replacement market segmentation by geography 2015-2020
Exhibit 09: Transcatheter mitral valve replacement market in Americas 2015-2020 ($ millions)
Exhibit 10: Transcatheter mitral valve replacement market in EMEA 2015-2020 ($ millions)
Exhibit 11: Transcatheter mitral valve replacement market in APAC 2015-2020 ($ millions)
Exhibit 12: Impact of drivers
Exhibit 13: Impact of drivers and challenges
Exhibit 14: Major acquisitions 2015
Exhibit 15: Products of few vendors 2015
Exhibit 16: Abbott Laboratories: Key takeaways
Exhibit 17: Edwards Lifesciences: Business segmentation by revenue 2014
Exhibit 18: Edwards Lifesciences: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 19: Edwards Lifesciences: Key takeaways
Exhibit 20: Micro Interventional Devices: Key takeaways
Exhibit 21: Neovasc: Geographical segmentation by revenue 2014
Exhibit 22: Neovasc: Key takeaways
Exhibit 23: Other vendors
Exhibit 24: Emerging vendors
